Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Superficial cancer in Nigeria.
1969
Basal cell epithelioma in black patients
1987
Superficial Cancer in the Sudan. A Study of 1225 Primary Malignant Superficial Tumours
1974
Cancer treatment and survivorship statistics, 2022
2022 Standout
Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Cancer
2017
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Antibody-drug conjugates for cancer therapy: The technological and regulatory challenges of developing drug-biologic hybrids
2015
Targeted therapies in breast cancer: are heart and vessels also being targeted?
2012
Natural products: A continuing source of novel drug leads
2013 Standout
Sublobar Resection: A Movement from the Lung Cancer Study Group
2010
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
2016
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Changing role of invasive aspergillosis in AIDS — a case control study
1998
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer
2007
Immunoconjugates and long circulating systems: Origins, current state of the art and future directions
2012
Skin cancer in skin of color
2006
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Antibody drug conjugates
2014
The Protective Role of Melanin Against UV Damage in Human Skin†
2007 Standout
Cancer stem cells revisited
2017 Standout
Current approach to the treatment of chronic myeloid leukaemia
2017
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
The Epidemiology of Skin Cancer
1996 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Preclinical and clinical development of inotuzumab-ozogamicin in hematological malignancies
2014
Antibody–drug conjugates: targeted drug delivery for cancer
2010
Crohn's disease
2016 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma
2008
Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia
2007
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
2011
Video-Assisted Thoracic Surgery for Pulmonary Aspergilloma: A Safe and Effective Procedure
2013
Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
2016
8thAnnual European Antibody Congress 2012
2013
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Site-specific chemical protein conjugation using genetically encoded aldehyde tags
2012 StandoutNobel
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Enoxaparin 40 mg per Day Is Inadequate for Venous Thromboembolism Prophylaxis After Thoracic Surgical Procedure
2018
The PI3K Pathway in Human Disease
2017 Standout
New developments for antibody-drug conjugate-based therapeutic approaches
2016
Antibody‐Drug Conjugates for the Treatment of Cancer
2012
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy
2014
BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB
2012
Ensuring Fairness in Machine Learning to Advance Health Equity
2018 Standout
Boosted SVM for extracting rules from imbalanced data in application to prediction of the post-operative life expectancy in the lung cancer patients
2013
Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors
2009
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
2017 Standout
Clinical Practice Guideline for the Surgical Management of Crohn’s Disease
2015
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
1985 Standout
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Spermidine in health and disease
2018 StandoutScience
Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates
2011
Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors
2021
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Learning from class-imbalanced data: Review of methods and applications
2016 Standout
Antibody-Drug Conjugates in Cancer Therapy
2012
Natural product and natural product derived drugs in clinical trials
2014 Standout
Formylglycine, a Post-Translationally Generated Residue with Unique Catalytic Capabilities and Biotechnology Applications
2014 StandoutNobel
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Pneumocystis jiroveciiPneumonia in Everolimus-Treated Renal Cell Carcinoma
2014
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
2014 StandoutNobel
Human Papillomaviruses and Their Possible Role in Squamous Cell Carcinomas
1977 StandoutNobel
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Sensitive ELISA Method for the Measurement of Catabolites of Antibody–Drug Conjugates (ADCs) in Target Cancer Cells
2015
Brentuximab Vedotin (SGN-35)
2011
Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors
2014
Recovery From Marrow Failure Following Isogenic Marrow Infusion
1964 StandoutNobel
Oxime Ligation on the Surface of Mesoporous Silica Nanoparticles
2015 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Primary Carcinoma of The Liver
1958
UV Radiation and the Skin
2013 Standout
NITROGEN-MUSTARD THERAPY COMBINED WITH AUTOLOGOUS MARROW INFUSION
1961
Malignant Melanoma in a Patient with Oculocutaneous Albinism
2000
Works of Mark Shapiro being referenced
Drug-Related Pneumonitis in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus
2011
Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study
2010
Malignant disease in the Transvaal. II. Tumours of the musculo-skeletal system. III. Cancer of the respiratory tract; first statistical report of the radiation therapy department of the Johannesburg group of hospitals.
1955
Malignant disease in the Transvaal. I. Cancer of the skin; first statistical report from the Radiation Therapy Department of the Johannesburg group of hospitals.
1952
Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors
2006
An Aggressive Approach to Extrahepatic Cholangiocarcinomas Is Warranted: Margin Status Does Not Impact Survival after Resection
2008
Thoracoscopic segmentectomy compares favorably with thoracoscopic lobectomy for patients with small stage I lung cancer
2009
Nodal Upstaging in Robotic and Video Assisted Thoracic Surgery Lobectomy for Clinical N0 Lung Cancer
2015
Predictors of Major Morbidity and Mortality After Pneumonectomy Utilizing The Society for Thoracic Surgeons General Thoracic Surgery Database
2010
Endoscopy in the age of HIV: A study of current practices and attitudes
1994
Surgical Management and Outcomes of Patients with Duodenal Crohn's Disease
2008
Safety of Neratinib (HKI-272) in Combination with Capecitabine in Patients with Solid Tumors: A Phase 1/2 Study.
2009
Safety and Clinical Activity of the Anti-CD22 Immunoconjugate Inotuzumab Ozogamicin (CMC-544) in Combination with Rituximab in Follicular Lymphoma or Diffuse Large B-Cell Lymphoma: Preliminary Report of a Phase 1/2 Study
2008
Health-related quality of life during bosutinib (SKI-606) therapy in patients with advanced chronic myeloid leukemia after imatinib failure
2016
Long‐term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors
2015
Long-term evaluation of vascular toxicity in patients with Ph+ leukemias treated with bosutinib.
2014
Skin Cancer in the South African Bantu
1953
Clinical Activity of the Immunoconjugate CMC-544 in B-Cell Malignancies: Preliminary Report of the Expanded Maximum Tolerated Dose (MTD) Cohort of a Phase 1 Study.
2006
Experimental Radiotherapy of Abdominal Cancer—IV. Radiosensitivity of Liver Tumours
1954